Ke Si Wang
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Medicinal plant effects and applications
Papers in
-
- Natural product bioactivities and synthesis 5
- PI3K/AKT/mTOR signaling in cancer 3
- Bioactive natural compounds 2
-
- Cancer, Hypoxia, and Metabolism 6
- NF-κB Signaling Pathways 5
- Cancer-related molecular mechanisms research 2
- Co-authors
- Juan Ma (14 shared papers)Chunliu Mi (15 shared papers)Lian Xun Piao (9 shared papers)Guang Xu (9 shared papers)Xuezheng Li (9 shared papers)Xuejun Jin (8 shared papers)Jung Joon Lee (8 shared papers)Xuejun Jin (6 shared papers)
- Journals
- Oncology Reports (3 papers)Immunopharmacology and Immunotoxicology (2 papers)Chemico-Biological Interactions (2 papers)International Immunopharmacology (2 papers)Phytotherapy Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ke Si Wang
15 papers receiving 555 citations
Peers
Comparison fields: 5 of 87
- Toxicology 32
- Complementary and alternative medicine 73
- Cancer Research 115
- Pharmacology 94
- Pharmacology 43
Countries citing papers authored by Ke Si Wang
This map shows the geographic impact of Ke Si Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Si Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Si Wang more than expected).
Fields of papers citing papers by Ke Si Wang
This network shows the impact of papers produced by Ke Si Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Si Wang. The network helps show where Ke Si Wang may publish in the future.
Co-authors
The 22 scholars most cited alongside Ke Si Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 99 | |
| 2 | 2016 | 89 | |
| 3 | 2017 | 50 | |
| 4 | 2016 | 47 | |
| 5 | 2017 | 46 | |
| 6 | 2016 | 44 | |
| 7 | 2016 | 43 | |
| 8 | 2015 | 38 | |
| 9 | 2017 | 27 | |
| 10 | 2016 | 22 | |
| 11 | 2017 | 19 | |
| 12 | 2015 | 13 | |
| 13 | 2015 | 12 | |
| 14 | 2016 | 6 | |
| 15 | 2021 | 1 |
About Ke Si Wang
Ke Si Wang is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Oncology and Complementary and alternative medicine, having authored 15 papers that have together received 556 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Natural product bioactivities and synthesis (5 papers), NF-κB Signaling Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Bioactive natural compounds (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer-related molecular mechanisms research (2 papers) and Medicinal Plant Pharmacodynamics Research (1 paper). The work is most often cited by research in Toxicology (32 citations), Complementary and alternative medicine (73 citations), Cancer Research (115 citations), Pharmacology (94 citations) and Pharmacology (43 citations). Ke Si Wang has collaborated with scholars based in China and United States. Frequent co-authors include Juan Ma, Chunliu Mi, Lian Xun Piao, Guang Xu, Xuezheng Li, Xuejun Jin, Jung Joon Lee, Xuejun Jin, Zhe Wang and Ming Yue Li. Their work appears in journals such as Oncology Reports, Immunopharmacology and Immunotoxicology, Chemico-Biological Interactions, International Immunopharmacology and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.